|
2026
|
Invention
|
The salts of a compound and the crystalline forms thereof.
The present invention relates to the ... |
|
2025
|
Invention
|
Amide compounds and uses thereof.
Provided herein are novel amide compounds of formula (I), phar... |
|
|
Invention
|
Cycloolefin substituted heteroaromatic compounds and their use.
Compounds of formula (I) or a ph... |
|
2024
|
Invention
|
Salts of a compound and the crystalline forms thereof.
The present invention belongs to the phar... |
|
|
Invention
|
Heteroaryl heterocyclic compounds and uses thereof.
The present invention relates to heteroaryl ... |
|
|
Invention
|
Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor... |
|
|
Invention
|
Anti-ox40 antibody and uses thereof.
The present invention provides an anti-OX40 antibody or ant... |
|
2023
|
Invention
|
Substituted piperazines as btk inhibitors. The present invention relates to heteroaryl heterocycl... |
|
|
Invention
|
Crystalline forms of (s)-4-amino-6-((1-(3-chloro-6-phenylimidazo[1,2-b]pyridazine-7-yl)ethyl)amin... |
|
2022
|
Invention
|
Substituted pyridines, pyridazines, pyrimidines, and 1,2,3-triazines as bruton's tyrosine kinase ... |
|
|
Invention
|
Anti-ox40 antibody and uses thereof. The present invention provides an anti-OX40 antibody or anti... |
|
|
Invention
|
Salts of a compound and the crystalline forms thereof. The present invention belongs to the pharm... |
|
|
Invention
|
Cycloolefin substituted heteroaromatic compounds and their use. 8, m, and n are as defined in the... |
|
|
Invention
|
Substituted piperazines as btk inhibitors. Provided are heteroaryl heterocyclic compounds of form... |
|
2021
|
Invention
|
2-(3′-(hydroxymethyl)-1-methyl-5-((5-(2-methyl-4-(oxetan-3-yl)piperazin-1-yl)pyridin-2-yl)amino)-... |
|
|
Invention
|
Heteroaromatic compounds and uses thereof.
Providing heteraromatic compounds and uses thereof. I... |
|
|
Invention
|
Heteroaryl heterocyclic compounds and uses thereof. Provided are heteroaryl heterocyclic compound... |
|
|
Invention
|
Heteroaromatic compounds and uses thereof. Providing heteraromatic compounds and uses thereof. In... |
|
|
Invention
|
Methods of using surufatinib in treating advanced pancreatic and extra-pancreatic neuroendocrine ... |
|
|
Invention
|
Pyrimidinone compounds and uses thereof. The present invention relates to pyrimidinone compounds ... |
|
|
Invention
|
Pyrimidinone compounds and uses thereof. It relates to pyrimidinone compounds and uses thereof. I... |
|
|
Invention
|
Anti-ox40 antibody and method of treatment. Provided are an anti-OX40 antibody or antigen-binding... |
|
|
Invention
|
Anti-ox40 antibody and uses thereof. Provided are an anti-OX40 antibody or antigen-binding fragme... |
|
|
Invention
|
Anti-cd47 antibody and uses thereof. The present invention provides an anti-CD47 antibody or anti... |
|
|
Invention
|
Anti-cd47 antibody and uses thereof. Provided is an anti-CD47 antibody or antigen-binding fragmen... |
|
|
Invention
|
Amide compounds and uses thereof. The present invention relates to novel amide compounds of formu... |
|
|
Invention
|
Amide compounds and uses thereof. Provided herein are novel amide compounds of formula (I), pharm... |
|
|
Invention
|
Pharmaceutical combination of anti-pd-1 antibody and multi-receptor tyrosine kinase inhibitor and... |
|
|
Invention
|
Heteroaryl heterocyclic compounds and uses thereof. Provided herein are heteroaryl heterocyclic c... |
|
|
Invention
|
Use of anti-pd-1 antibody in combination with fruquintinib in preparation of medicaments for trea... |
|
|
Invention
|
Pharmaceutical composition of anti-pd-1 antibody and quinazoline derivative, uses of composition,... |
|
2020
|
Invention
|
Novel amide compounds and uses thereof. The present invention relates to novel amide compounds, p... |
|
|
Invention
|
Salts of a compound and the crystalline forms thereof. The present invention relates to the salts... |
|
|
Invention
|
Crystalline forms of inhibitors of fibroblast growth factor and their use in pharmaceutical compo... |
|
|
Invention
|
The salts of a compound and the crystalline forms thereof. The present invention relates to the s... |
|
|
Invention
|
Tricyclic compounds and their use. Tricyclic compounds and their use are provided. More specifica... |
|
2019
|
Invention
|
Method for the manufacture of 3-[(1s)-1-imidazo[1,2-a]pyridin-6-ylethyl]-5-(1-methylpyrazol-4-yl)... |
